Talyst names new CEO
Ms Corkern has been with the company for two years, serving as COO, then interim CEO. She also serves on Talyst’s board of directors. She has more than
10x Genomics has entered into a multi-project research agreement with Fred Hutchinson Cancer Center (Fred Hutch) for advancing single cell as well as spatial platforms in solid tumours and blood cancers.
Novavax said that the vaccine, which does not contain an adjuvant, induced robust neutralizing antibody responses. Novavax’s virus-like particle (VLP) candidate is directed against the H5N1 A/Indonesia/05/2005 avian